AstraZeneca Pharma India board to consider unaudited financial results

23 Jan 2013 Evaluate

AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on February 06, 2013, to consider and approve the unaudited financial results of the company for the third quarter and nine months ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

6336.90 48.00 (0.76%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.